"Hof" in pronormoblasts: pure erythroid leukemia mimicking plasma cell myeloma

Blood. 2017 Sep 28;130(13):1600. doi: 10.1182/blood-2017-07-796466.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Azacitidine / therapeutic use
  • Cyclophosphamide / administration & dosage
  • Cyclophosphamide / adverse effects
  • Cytoplasm / ultrastructure*
  • Dexamethasone / administration & dosage
  • Dexamethasone / adverse effects
  • Diagnostic Errors*
  • Erythroblasts / ultrastructure*
  • Fatal Outcome
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Lenalidomide
  • Leukemia, Erythroblastic, Acute / blood
  • Leukemia, Erythroblastic, Acute / diagnosis*
  • Leukemia, Erythroblastic, Acute / pathology
  • Male
  • Multiple Myeloma / blood
  • Multiple Myeloma / diagnosis*
  • Myelodysplastic Syndromes / blood*
  • Myelodysplastic Syndromes / chemically induced
  • Myelodysplastic Syndromes / pathology
  • Thalidomide / analogs & derivatives
  • Thalidomide / therapeutic use

Substances

  • Thalidomide
  • Dexamethasone
  • Cyclophosphamide
  • Lenalidomide
  • Azacitidine